RFP
NPCE icon

Root Financial Partners’s Neuropace NPCE Stock Holding History

Root Financial Partners’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33
Closed -$434 – 2211
2026
Q1 		$434 Buy
+33
New +$495 ﹤0.01% 2913

Other funds holding NPCE

PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return
HFS
Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Root Financial Partners's NPCE Position: Q2 2026 in Review

Root Financial Partners sold out of Neuropace (NPCE) in Q2 2026, closing a stake of 33 shares — an estimated $434 sold.

Root Financial Partners first reported a position in NPCE in Q1 2026 and held it in 1 quarter. The position peaked at $434 in Q1 2026. 11 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Root Financial Partners reported no remaining Neuropace position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 33 Neuropace shares in Q2 2026, an estimated $434.
  • Root Financial Partners first reported a position in Neuropace in Q1 2026 and held it in 1 quarter.
  • Root Financial Partners's Neuropace position peaked at $434 in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.